Findings
========

The transmission cycles of flaviviruses require successful utilization of cellular receptors in a wide variety of organisms including mammals, avians or arthropods. Although several molecules of mammalian origin have been proposed as putative receptors for mosquito-borne flaviviruses, knowledge about arthropod receptors remains limited \[[@B1]\]. Flavivirus receptor-binding activity in mammals was first shown to be mediated by the domain III of envelope protein (EDIII), eventually localized to the FG loop \[[@B2],[@B3]\]. Although the sequences and structures of the FG loop among mosquito-borne and tick-borne flaviviruses are largely conserved, minor differences were still observed in the FG loop not only between both types of flaviviruses but also among mosquito-borne flaviviruses that utilize different vector species. Interestingly, the FG loops of mosquito-borne flavivirus EDIII are invariably longer than those of tick-borne flavivirus EDIII, which lack the RGD (Arg-Gly-Asp) motif. Inhibition of virus entry by peptides resembling the DENV-2 FG loop in mosquito cells *in vitro* first suggested its role in determining vector specificity \[[@B3]\]. Alignment of the amino acid sequences of mosquito-borne flaviviruses further demonstrated the RGD motif, especially the Arg and Gly residues, was largely conserved in the mosquito-borne flaviviruses in the JEV serocomplex, which utilize a substantially larger spectrum of host and vector species than other flaviviruses \[[@B4],[@B5]\]. However, attenuated YFV 17D strains have the RGD motif while the virulent Asibi parental strain contains a Thr instead of Arg at position 380 \[[@B4]\]. These data highlight the need for understanding the function of the conserved Arg residue, which has been identified as a determinant of binding efficiency to negatively charged host molecules among flaviviruses \[[@B6]\]. Although characterization of the RGD motif has been performed in JEV, WNV, MVEV and YFV in mice, knowledge of its interaction with arthropod receptors remains limited \[[@B6]-[@B8]\]. Length of the corresponding region in DENV-2 EDIII played a more significant role than the sequence in infectivity, and substitution with the sequence of YFV 17D strain did not significantly decrease infectivity in *Aedes aegypti*. However, the sequence of YFV Asibi strain, which is more infectious and disseminates at higher rates in *Ae. aegypti*, was not evaluated \[[@B9]-[@B11]\]. More importantly, this model provided limited information on the RGD motif function due to the lack of conservation of this motif among the four DENV serotypes. Therefore, we utilized the YFV reverse genetics system to evaluate the impact of the Thr380Arg (T380R) mutation in EDIII on the viral infectivity and dissemination in *Ae. aegypti*. Such knowledge will increase understanding of the RGD-motif-dependent viral entry mechanisms among mosquito-borne flaviviruses utilizing different vectors.

Introduction of T380R mutation in E of infectious clones of YFV Asibi strain and 17D/Asibi M-E chimera was achieved by subcloning the structural genes into the pGEM®-T Easy vector (Promega, Madison, WI) followed by PCR site-directed mutagenesis with Quikchange®II XL kit (Stratagene, La Jolla, CA) and ligation of *BspE*I (New England Biolabs, Ipswich, MA)- and *Mlu*I (New England Biolabs)- digested plasmids as previously described \[[@B12]\]. Rescued viruses were obtained via electroporation of *in vitro* transcribed viral RNA in BHK-21 cells maintained in MEM-α media (Life technologies, Carlsbad, CA) supplemented with 10% FBS (Life technologies). Freshly harvested viruses mixed with defibrinated sheep blood were presented to 6 to 8-day-old *Ae. aegypti* RexD WE strain through a Hemotek membrane feeding apparatus (Discovery Workshop, Lancashire, England UK) at 37C for 60 minutes. Engorged mosquitoes were maintained with 10% sucrose solution at 16 hr:8 hr light--dark photoperiod for 14 days. Mosquitoes were cold anesthetized and dissected to collect the body and secondary tissues including the head, wings and legs of individual mosquitoes at 7, 10, and 14 days post infection (d.p.i.). The secondary tissues were used as the indicator for viral dissemination based on the disseminating phenotypes of the Asibi strain which causes the presence of infectious viruses in the head, wings and legs after the establishment of infection in the midgut \[[@B13]\]. Viral replication kinetics were assessed by titration of homogenized whole mosquitoes by TCID~50~ as described previously \[[@B10]\]. Infection was defined as the positive immunofluorescence staining in the serially-diluted homogenates of whole mosquito, body or secondary tissues in Vero cells. Dissemination was defined by the positive immunofluorescence staining in the homogenates derived from the secondary tissues in Vero cells. Fisher's exact test was used to analyze the infection and dissemination rates and ANOVA was performed for the analysis of the titers of infected whole mosquitoes.

The infection and dissemination rates for all groups are summarized in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. The T380R mutation did not abolish viral infectivity, as similar infection rates of Asibi strain and Asibi E T380R mutant were observed at 7 (60.6% vs. 66.7%), 10 (50% vs.58.3%) and 14 (55.3% vs. 53.8%) d.p.i. Interestingly, a significantly higher infection rate was observed for the 17D/Asibi M-E E T380R mutant compared to the wild-type 17D/Asibi M-E chimera at 7 d.p.i. (91.3% vs. 41.4%,) and 14 d.p.i. (87.5% vs. 53.8%) (*p* \< 0.05) although infection rates were not significantly higher at 10 d.p.i. The establishment of infection also led to similar dissemination rates both between the Asibi strain and Asibi E T380R mutant and between the 17D/Asibi M-E chimera and 17D/Asibi M-E E T380R mutant at 7, 10 and 14 d.p.i. Virus titers in whole mosquitoes were not significantly different for any group (Figure [1](#F1){ref-type="fig"}).

###### 

***Ae. aegypti*infection rates, calculated as number infected whole mosquitoes and bodies/tested**

                             **Average blood meal titer (logTCID**~**50**~**/ml)**   **7 d.p.i.**   **10 d.p.i.**   **14 d.p.i.**                     
  -------------------------- ------------------------------------------------------- -------------- --------------- --------------- --------- ------- ------------
  Defibrinated sheep blood   N.A.                                                    0/30           (0.0%)          0/24            (0.0%)    0/35    (0.0%)
  17D                        6.24                                                    9/25           (36.0%)         8/12            (66.7%)   8/32    (25.0%)
  17D/Asibi M-E              5.77                                                    12/29          (41.4%)         13/24           (54.2%)   21/39   (53.8%)
  17D/Asibi M-E E T380R      5.85                                                    21/23          (91.3%)^†^      10/12           (83.3%)   14/16   (87.5%)^†^
  Asibi                      3.99                                                    20/33          (60.6%)         9/18            (50.0%)   21/38   (52.6%)
  Asibi E T380R              4.21                                                    32/48          (66.7%)         21/36           (58.3%)   21/39   (53.8%)

^†^indicates the significant difference by Fisher's exact test from 17D/Asibi M-E chimera.

###### 

***Ae. aegypti*dissemination rates calculated as positive secondary tissues/tested**

                          **7 d.p.i.**   **10 d.p.i.**   **14 d.p.i.**                     
  ----------------------- -------------- --------------- --------------- --------- ------- ---------
  17D                     0/3            (0.0%)          1/5             (20.0%)   0/12    (0.0%)
  17D/Asibi M-E           2/6            (33.3%)         3/8             (37.5%)   7/14    (50.0%)
  17D/Asibi M-E E T380R   3/14           (21.4%)         1/6             (16.7%)   5/8     (62.5%)
  Asibi                   8/17           (47.1%)         4/5             (80.0%)   9/15    (60.0%)
  Asibi E T380R           15/19          (79.0%)         9/14            (64.3%)   10/15   (66.7%)

![**Titers of whole-mosquito homogenates of*Ae. aegypti*at 7, 10 and 14 d.p.i.**](1743-422X-11-60-1){#F1}

Our results demonstrated the change in the biochemical properties between Thr and Arg did not reduce the viral infectivity and subsequent dissemination of YFV in *Ae. aegypti*. 17D/Asibi M-E E T380R mutant was able to infect a significantly higher percentage of mosquitoes at 7 and 14 d.p.i. than the 17D/Asibi M-E chimera, which was previously shown to have the lower infectivity due to the attenuation by the chimerization \[[@B12]\]. However, the results showed the likelihood of transmission should not be enhanced due to the similar dissemination rates between the wild-type and mutant viruses. The observation was partially consistent with the previously published study on DENV-2 based on the fact that the infectivity was maintained whilst the length of FG-loop was not altered. The more plausible explanation for the increased infectivity due to the T380R mutation may be that the gain of positive charge leads to the more efficient viral attachment to the target cells in the host and the higher infection rates. Although the increase of positive charges on viral structural proteins has been known to reduce the viral dissemination, most mutant viruses still retain the infectivity for susceptible host cells. The presence of the positive charges on the E2 glycoprotein of the mosquito-borne alphavirus eastern equine encephalitis virus led to the higher number of infected brain cells in mice intracerebrally challenged, indicating the presence of positively charged amino acids may be advantageous for the establishment of infection \[[@B14]\]. In the case of adeno-associated virus, the gain of positive charge through the similar Thr➔Arg mutation in the capsid region significantly increased the viral attachment to HeLa cells \[[@B15]\]. Our results suggest that the presence of the positively charged arginine on the FG loop may favor the establishment of infection in mosquitoes. Understanding the function of flavivirus RGD motifs and FG loops in viral infection and dissemination can only be achieved by further testing the hypothesis with the reverse genetics systems of *Culex*-borne flaviviruses, tick-borne flaviviruses and the newly discovered mosquito-only flaviviruses.
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